**Selected for 2025 Doody’s Core Titles® in Family Medicine**
For nearly 30 years Ferri’s Clinical Advisor has provided immediate answers on the myriad medical diseases and disorders you’re likely to encounter in a unique, easy-to-use format. A bestselling title year after year, this popular "5 books in 1" reference delivers vast amounts of information in a user-friendly manner. It is updated annually to provide current and clinically relevant answers on over 1,000 common medical conditions across sections focusing on diseases and disorders, differential diagnoses, clinical algorithms, laboratory tests, and clinical practice guidelines―all carefully reviewed by experts in key clinical fields. Extensive algorithms, along with hundreds of high-quality photographs, illustrations, diagrams, and tables, ensure that you stay current with today's medical practice.
1. Introduction - p. 1458 2. Clinical Algorithms - p. 1459 3. ABDOMINAL ABSCESS - p. 1459 4. ABDOMINAL PAIN, ACUTE - p. 1461 5. ABDOMINAL PAIN, RIGHT UPPER QUADRANT - p. 1470 6. ACID-BASE HOMEOSTASIS - p. 1471 7. ACIDOSIS, METABOLIC - p. 1474 8. ACIDOSIS, RESPIRATORY, ACUTE - p. 1477 9. ACIDOSIS, RESPIRATORY, CHRONIC - p. 1478 10. AIRWAY OBSTRUCTION, MALIGNANT - p. 1480 11. ALKALOSIS, METABOLIC - p. 1480.e1 12. ALKALOSIS, RESPIRATORY TREATMENT - p. 1482 13. ALLERGIC REACTION TO VACCINES - p. 1483 14. ALTERED MENTAL STATUS AND COMA - p. 1483.e1 15. ALVEOLAR FILLING DISORDERS - p. 1484 16. ALVEOLAR HEMORRHAGE - p. 1484.e1 17. AMBIGUOUS GENITALIA - p. 1484.e3 18. ANEMIA - p. 1484.e5 19. ANEMIA, MACROCYTIC - p. 1486 20. ANEMIA, MICROCYTIC - p. 1487 21. ANISOCORIA - p. 1489 22. ANORECTAL COMPLAINTS - p. 1490.e1 23. AZOOSPERMIA - p. 1492 24. BACK PAIN - p. 1492.e1 25. BLEEDING AND BRUISING PROBLEMS - p. 1498 26. BLEEDING DISORDERS - p. 1502 27. BLEEDING, PATIENT ON DABIGATRAN - p. 1503 28. BLEEDING, PATIENT ON ORAL FACTOR XA INHIBITORS - p. 1503.e2 29. BRADYCARDIA - p. 1503.e4 30. BREAST LUMP - p. 1504 31. BULLAE ON LOWER EXTREMITIES - p. 1505 32. CAFÉ-AU-LAIT MACULES - p. 1505.e1 33. CARDIAC ARREST - p. 1505.e3 34. CARDIOGENIC SHOCK - p. 1509 35. CARDIOMEGALY ON CHEST X-RAY EXAMINATION - p. 1509.e1 36. CARDIOMYOPATHY - p. 1512 37. CAUSTIC INGESTION - p. 1514 38. CHEST PAIN - p. 1514.e1 39. CENTRAL NERVOUS SYSTEM INFECTION, PRESUMED - p. 1517 40. CONFUSION - p. 1518 41. CONNECTIVE TISSUE DISORDER, SUSPECTED - p. 1521 42. CONNECTIVE TISSUE LABORATORY TESTS - p. 1522 43. CONVULSIVE DISORDER, SUSPECTED, PEDIATRIC PATIENT - p. 1524 44. COUGH, CHRONIC - p. 1524.e1 45. CYSTITIS, ACUTE - p. 1528 46. DAYTIME SLEEPINESS, PEDIATRIC PATIENT - p. 1528.e1 47. DEFECATION DISORDER, PEDIATRIC AGE - p. 1528.e2 48. DIARRHEA, ACUTE - p. 1528.e3 49. DIARRHEA, WATERY - p. 1531 50. DILATED PUPIL - p. 1531.e1 51. DYSPNEA - p. 1531.e2 52. EDEMA - p. 1535 53. EPILEPSY - p. 1536 54. ERYTHROCYTOSIS, ACQUIRED - p. 1536.e2 55. ESOPHAGEAL FOREIGN BODY - p. 1537 56. ESOPHAGEAL PERFORATION - p. 1537.e2 57. EXANTHEMATOUS DRUG REACTION - p. 1537.e4 58. FEVER AND INFECTION IN HIGH-RISK HEMATOLOGY PATIENT WITHOUT OBVIOUS SOURCE - p. 1539 59. FEVER AND NEUTROPENIA - p. 1539.e1 60. FEVER AND NEUTROPENIA, PEDIATRIC PATIENT - p. 1543 61. FEVER AND RASH - p. 1543.e1 62. GASTROINTESTINAL BLEEDING - p. 1544 63. GASTROINTESTINAL FISTULA - p. 1549 64. GOITER EVALUATION AND MANAGEMENT - p. 1549.e1 65. GRANULOMA, NONINFECTIOUS - p. 1549.e2 66. HEADACHE - p. 1549.e4 67. HEARING LOSS - p. 1554 68. HEMATOCHEZIA, MANAGEMENT - p. 1561 69. HEMATURIA, PEDIATRIC PATIENT - p. 1561.e1 70. HEPATIC MASS - p. 1563 71. HEPATOMEGALY - p. 1564 72. HYPERCALCEMIA - p. 1566 73. HYPERCAPNIA - p. 1569 74. HYPERPIGMENTATION - p. 1570 75. HYPOTENSION - p. 1570.e3 76. HYPOTENSION, POSTOPERATIVE - p. 1571 77. HYPOVOLEMIC SHOCK - p. 1571.e1 78. HYPOXEMIA - p. 1571.e2 79. HYPOXEMIA, POSTOPERATIVE - p. 1572 80. INFECTIONS OF SOFT TISSUE, JOINTS, AND BONE - p. 1572.e1 81. INTRAABDOMINAL INFECTION, SUSPECTED - p. 1573 82. JOINT EFFUSION - p. 1574 83. JOINT PAIN AND SWELLING - p. 1575 84. LEG ULCERS - p. 1579 85. LIMB ISCHEMIA, ACUTE - p. 1580 86. LIVER FUNCTION TEST ELEVATIONS - p. 1581 87. LIVER MASS - p. 1582.e1 88. MEDIASTINAL MASS - p. 1583 89. MENTAL STATUS CHANGE, ELDERLY PATIENT - p. 1585 90. MUSCULOSKELETAL COMPLAINTS - p. 1586 91. MUSCULOSKELETAL PAIN, CHRONIC - p. 1587 92. NAUSEA AND VOMITING - p. 1589 93. NECK MASS - p. 1595 94. NECK PAIN - p. 1596 95. OLIGURIA - p. 1600 96. OTALGIA AND OTORRHEA - p. 1602 97. PALPITATIONS, DIZZINESS, AND/OR SYNCOPE - p. 1603 98. PANCREATIC ISLET CELL TUMORS - p. 1604 99. PANCREATIC MASS - p. 1604.e2 100. PELVIC PAIN, WOMEN, DIAGNOSTIC EVALUATION - p. 1605 101. PELVIC PAIN, WOMEN, MANAGEMENT - p. 1607 102. PERIPHERAL NEUROPATHY - p. 1608 103. PHOTOSENSITIVITY - p. 1612 104. PLEURAL INFECTION - p. 1612.e1 105. PNEUMOTHORAX, TRAUMATIC - p. 1614 106. POLYURIA - p. 1615 107. PREMATURE VENTRICULAR COMPLEXES - p. 1616 108. PROTEINURIA IN CHILDREN - p. 1616.e1 109. PRURITUS IN PREGNANT WOMAN - p. 1616.e2 110. PULMONARY NODULE - p. 1616.e3 111. PURPURA - p. 1620 112. RASH, ACUTE GENERALIZED SKIN ERUPTION - p. 1620.e1 113. RECTAL ULCER - p. 1620.e2 114. RED AND PAINFUL EYE - p. 1620.e3 115. RED EYE - p. 1621 116. RENAL MASS - p. 1621.e3 117. RENAL TRAUMA - p. 1622.e1 118. RHINITIS - p. 1622.e2 119. SCROTAL MASS - p. 1622.e3 120. SEIZURES, NEWBORN - p. 1623 121. SHOCK - p. 1623.e2 122. SHORT STATURE - p. 1623.e7 123. SHOULDER PAIN - p. 1623.e8 124. SKIN AND SOFT TISSUE INFECTIONS - p. 1623.e12 125. SLEEP DISORDERS ASSOCIATED WITH PREGNANCY - p. 1623.e15 126. SLEEP DISORDERS NOT CHARACTERIZED BY HYPERSOMNIA - p. 1623.e16 127. SLEEP-RELATED MOVEMENT DISORDERS - p. 1623.e17 128. SORE THROAT - p. 1624 129. SPINAL METASTATIC DISEASE - p. 1626 130. SPLENIC INJURY - p. 1626.e2 131. TACHYCARDIA, DIAGNOSTIC APPROACH - p. 1626.e4 132. TACHYCARDIA, NARROW COMPLEX - p. 1628 133. TACHYCARDIA, PEDIATRIC PATIENT - p. 1629 134. TACHYCARDIA, WIDE QRS - p. 1629.e1 135. TESTICULAR MASS - p. 1630 136. THROMBOTIC MICROANGIOPATHIES, DIFFERENTIAL DIAGNOSIS - p. 1631 137. TRAUMA IN PREGNANCY - p. 1631.e1 138. TRAUMATIC AORTIC INJURY - p. 1631.e2 139. URETHRAL DISCHARGE OR DYSURIA - p. 1631.e3 140. URINARY SYMPTOMS, LOWER URINARY TRACT - p. 1632 141. URINARY TRACT OBSTRUCTION - p. 1634 142. VAGINAL DISCHARGE, EVALUATION - p. 1635 143. VAGINITIS, PEDIATRIC - p. 1636 144. VENTILATOR-ASSOCIATED PNEUMONIA - p. 1637 145. VENTRICULAR FIBRILLATION OR PULSELESS VENTRICULAR TACHYCARDIA - p. 1637.e1 146. VERTIGO - p. 1637.e2 147. VIRAL EXANTHEM - p. 1640 148. VOMITING, ACUTE, MANAGEMENT - p. 1640.e1 149. WEAKNESS - p. 1640.e3 150. WEIGHT LOSS, UNINTENTIONAL - p. 1645 151. SECTION IV. Laboratory Tests and Interpretation of Results - p. 1649 152. Introduction - p. 1650 153. Laboratory Tests and Interpretation of Results - p. 1650 154. ACE LEVEL - p. 1650 155. ACETONE (SERUM OR PLASMA) - p. 1651 156. ACETYLCHOLINE RECEPTOR (AChR) ANTIBODY - p. 1651 157. ACID-BASE REFERENCE VALUES - p. 1651 158. ACID PHOSPHATASE (SERUM) - p. 1651 159. ACID SERUM TEST - p. 1651 160. ACTIVATED CLOTTING TIME (ACT) - p. 1651 161. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT, aPTT) - p. 1651 162. ADRENOCORTICOTROPIC HORMONE (ACTH) - p. 1651 163. ALANINE AMINOPEPTIDASE - p. 1651.e1 164. ALANINE AMINOTRANSFERASE (ALT, SGPT) - p. 1651.e1 165. ALBUMIN (SERUM) - p. 1651.e3 166. ALCOHOL DEHYDROGENASE - p. 1652 167. ALDOLASE (SERUM) - p. 1652 168. ALDOSTERONE - p. 1653 169. ALKALINE PHOSPHATASE (ALP) (SERUM) - p. 1653.e1 170. ALPHA-1-ANTITRYPSIN (SERUM) - p. 1653.e3 171. ALPHA-1-FETOPROTEIN (SERUM) - p. 1653.e3 172. ALT - p. 1653.e3 173. ALUMINUM (SERUM) - p. 1653.e3 174. AMA - p. 1653.e3 175. AMEBIASIS SEROLOGIC TEST - p. 1653.e3 176. AMINOLEVULINIC ACID (δ-ALA) (24-H URINE COLLECTION) - p. 1653.e3 177. AMMONIA (SERUM) - p. 1653.e3 178. AMYLASE (SERUM) - p. 1653.e4 179. AMYLASE, URINE - p. 1653.e5 180. AMYLOID A PROTEIN (SERUM) - p. 1653.e5 181. ANA - p. 1653.e5 182. ANCA - p. 1653.e5 183. ANDROSTENEDIONE (SERUM) - p. 1653.e5 184. ANGIOTENSIN II - p. 1653.e5 185. ANGIOTENSIN-CONVERTING ENZYME (ACE LEVEL) - p. 1653.e5 186. ANH - p. 1654 187. ANION GAP (AG) - p. 1654 188. ANTICARDIOLIPIN ANTIBODY (ACA) - p. 1654.e1 189. ANTICOAGULANT - p. 1654.e1 190. ANTIDIURETIC HORMONE - p. 1654.e1 191. ANTI-DNA - p. 1654.e3 192. ANTI-DS DNA - p. 1654.e3 193. ANTIGLOBULIN TEST - p. 1654.e3 194. ANTIGLOMERULAR BASEMENT ANTIBODY - p. 1654.e3 195. ANTIHISTONE - p. 1654.e3 196. ANTIMITOCHONDRIAL ANTIBODY (AMA, MITOCHONDRIAL ANTIBODY) - p. 1654.e3 197. ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) - p. 1654.e3 198. ANTINUCLEAR ANTIBODY (ANA) - p. 1654.e4 199. ANTI-RNP ANTIBODY - p. 1654.e7 200. ANTI-SCL-70 - p. 1654.e7 201. ANTI-SM (ANTI-SMITH) ANTIBODY - p. 1654.e7 202. ANTI-SMOOTH MUSCLE ANTIBODY - p. 1654.e7 203. ANTISTREPTOLYSIN O TITER (STREPTOZYME, ASLO TITER) - p. 1654.e7 204. ANTITHROMBIN III - p. 1655 205. APOLIPOPROTEIN A-1 (APO A-1) - p. 1655.e1 206. APOLIPOPROTEIN B (APO B) - p. 1655.e1 207. ARTERIAL BLOOD GASES - p. 1655.e1 208. ARTHROCENTESIS FLUID - p. 1655.e1 209. ASO TITER - p. 1655.e2 210. ASPARTATE AMINOTRANSFERASE (AST, SGOT) - p. 1655.e2 211. ATRIAL NATRIURETIC HORMONE (ANH) - p. 1656.e1 212. B-TYPE NATRIURETIC PEPTIDE (BNP) - p. 1656.e1 213. BASOPHIL COUNT - p. 1657 214. BICARBONATE - p. 1657 215. BILE, URINE - p. 1657 216. BILIRUBIN, DIRECT (CONJUGATED BILIRUBIN) - p. 1657 217. BILIRUBIN, INDIRECT (UNCONJUGATED BILIRUBIN) - p. 1657 218. BILIRUBIN, TOTAL - p. 1657 219. BILIRUBIN, URINE - p. 1657.e2 220. BLADDER TUMOR ASSOCIATED ANTIGEN - p. 1657.e2 221. BLEEDING TIME (MODIFIED IVY METHOD) - p. 1657.e2 222. BLOOD TYPE - p. 1657.e3 223. BLOOD VOLUME, TOTAL - p. 1657.e3 224. BNP - p. 1657.e3 225. BORDETELLA PERTUSSIS SEROLOGY - p. 1657.e3 226. BRCA ANALYSIS - p. 1657.e3 227. BREATH HYDROGEN TEST (HYDROGEN BREATH TEST) - p. 1658 228. BUN - p. 1658 229. C282Y AND H63D MUTATION ANALYSIS - p. 1658 230. C3 - p. 1658 231. C4 - p. 1658 232. CALCITONIN (SERUM) - p. 1658 233. CALCIUM (SERUM) - p. 1658 234. CALCIUM, URINE - p. 1658.e4 235. CANCER ANTIGEN 15-3 (CA 15-3) - p. 1659 236. CANCER ANTIGEN 27-29 (CA 27-29) - p. 1659 237. CANCER ANTIGEN 72-4 (CA 72-4) - p. 1659 238. CANCER ANTIGEN 125 (CA 125) - p. 1659 239. CAPTOPRIL STIMULATION TEST - p. 1659 240. CARBAMAZEPINE (TEGRETOL) - p. 1659 241. CARBAMAZEPINE LEVEL - p. 1659 242. CARBOHYDRATE ANTIGEN 19-9 - p. 1659 243. CARBON DIOXIDE, PARTIAL PRESSURE - p. 1659 244. CARBON MONOXIDE - p. 1659 245. CARBOXYHEMOGLOBIN - p. 1659 246. CARCINOEMBRYONIC ANTIGEN (CEA) - p. 1659 247. CAROTENE (SERUM) - p. 1660 248. CATECHOLAMINES, URINE - p. 1660 249. CBC - p. 1660 250. CD40 LIGAND - p. 1660 251. CEA - p. 1660.e1 252. CEREBROSPINAL FLUID (CSF) - p. 1660.e1 253. CERULOPLASMIN (SERUM) - p. 1661.e3 254. CHLAMYDIA GROUP ANTIBODY SEROLOGIC TEST - p. 1661.e3 255. CHLAMYDIA TRACHOMATIS PCR - p. 1661.e3 256. CHLORIDE (SERUM) - p. 1661.e3 257. CHLORIDE (SWEAT) - p. 1662 258. CHLORIDE, URINE - p. 1662 259. CHOLECYSTOKININ-PANCREOZYMIN (CCK, CCK-PZ) - p. 1662 260. CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN - p. 1662 261. CHOLESTEROL, LOW-DENSITY LIPOPROTEIN - p. 1662 262. CHOLESTEROL, TOTAL - p. 1662 263. CHORIONIC GONADOTROPINS, HUMAN (SERUM) (hCG) - p. 1662.e1 264. CHYMOTRYPSIN - p. 1662.e1 265. CIRCULATING ANTICOAGULANT (LUPUS ANTICOAGULANT) - p. 1662.e1 266. CK - p. 1662.e1 267. CLONIDINE SUPPRESSION TEST - p. 1662.e1 268. CLOSTRIDIUM DIFFICILE TOXIN ASSAY (STOOL) - p. 1662.e1 269. Co - p. 1662.e1 270. COAGULATION FACTORS - p. 1662.e1 271. COBALAMIN, SERUM - p. 1663.e1 272. COLD AGGLUTININS TITER - p. 1663.e1 273. COMPLEMENT - p. 1663.e1 274. COMPLETE BLOOD COUNT (CBC) - p. 1663.e2 275. CONJUGATED BILIRUBIN - p. 1663.e3 276. COPPER (SERUM) - p. 1663.e3 277. COPPER, URINE - p. 1663.e3 278. CORTICOTROPIN RELEASING HORMONE (CRH) STIMULATION TEST - p. 1663.e3 279. CORTISOL, PLASMA - p. 1663.e3 280. COOMBS DIRECT - p. 1663.e3 281. COOMBS INDIRECT - p. 1663.e3 282. COVID-19 - p. 1663.e3 283. C-PEPTIDE - p. 1663.e3 284. CPK - p. 1663.e3 285. C-REACTIVE PROTEIN - p. 1663.e3 286. C-REACTIVE PROTEIN, HIGH SENSITIVITY (hs-CRP, CARDIO-CRP) - p. 1665 287. CREATINE KINASE (CK, CPK) - p. 1665 288. CREATINE KINASE ISOENZYMES - p. 1665.e2 289. CREATININE (SERUM) - p. 1665.e2 290. CREATININE CLEARANCE - p. 1665.e3 291. CREATININE, URINE - p. 1665.e3 292. CRYOGLOBULINS (SERUM) - p. 1665.e3 293. CRYPTOSPORIDIUM ANTIGEN BY EIA (STOOL) - p. 1665.e3 294. CSF - p. 1665.e3 295. CYSTATIN C - p. 1665.e3 296. CYSTIC FIBROSIS PCR - p. 1665.e3 297. CYTOMEGALOVIRUS BY PCR - p. 1665.e3 298. d-DIMER - p. 1665.e3 299. DEHYDROEPIANDROSTERONE SULFATE - p. 1666 300. DEOXYCORTICOSTERONE (11-DEOXYCORTICOSTERONE, DOC) (SERUM) - p. 1666 301. DEXAMETHASONE SUPPRESSION TEST, OVERNIGHT - p. 1666 302. DIGOXIN - p. 1666 303. DIGOXIN LEVEL - p. 1666.e1 304. DIHYDROTESTOSTERONE (SERUM, URINE) - p. 1666.e1 305. DILANTIN - p. 1666.e1 306. DIRECT ANTIGLOBULIN (COOMBS DIRECT) - p. 1666.e1 307. DISACCHARIDE ABSORPTION TESTS - p. 1666.e1 308. DOC - p. 1666.e1 309. DONATH-LANDSTEINER (D-L) TEST FOR PAROXYSMAL COLD HEMOGLOBINURIA - p. 1666.e1 310. DOPAMINE - p. 1666.e1 311. D-XYLOSE ABSORPTION - p. 1666.e1 312. D-XYLOSE ABSORPTION TEST - p. 1667 313. ELECTROPHORESIS, HEMOGLOBIN - p. 1667 314. ELECTROPHORESIS, PROTEIN - p. 1667 315. ENA COMPLEX - p. 1667 316. ENDOMYSIAL ANTIBODIES - p. 1667 317. EOSINOPHIL COUNT - p. 1667 318. EPINEPHRINE, PLASMA - p. 1667.e2 319. EPSTEIN-BARR VIRUS SEROLOGY - p. 1667.e2 320. ERYTHROCYTE SEDIMENTATION RATE (ESR, SED RATE, SEDIMENTATION RATE) - p. 1667.e3 321. ERYTHROPOIETIN (EP) - p. 1667.e3 322. ESTRADIOL (SERUM) - p. 1667.e3 323. ESTROGEN - p. 1668 324. ETHANOL (BLOOD) - p. 1668 325. EXTRACTABLE NUCLEAR ANTIGEN (ENA COMPLEX, ANTI-RNP ANTIBODY, ANTI-SM, ANTI-SMITH) - p. 1668.e1 326. FACTOR V LEIDEN - p. 1668.e1 327. FASTING BLOOD SUGAR - p. 1668.e1 328. FBS - p. 1668.e1 329. FDP - p. 1668.e1 330. FECAL FAT, QUANTITATIVE (72-H COLLECTION) - p. 1668.e1 331. FECAL GLOBIN IMMUNOCHEMICAL TEST - p. 1668.e1 332. FERRITIN (SERUM) - p. 1668.e1 333. α-1 FETOPROTEIN - p. 1668.e1 334. FIBRIN DEGRADATION PRODUCT (FDP) - p. 1668.e1 335. FIBRINOGEN - p. 1668.e1 336. FOLATE (FOLIC ACID) - p. 1668.e1 337. FOLLICLE-STIMULATING HORMONE (FSH) - p. 1668.e2 338. FREE T4 - p. 1668.e2 339. FREE THYROXINE INDEX - p. 1668.e2 340. FTA-ABS (SERUM) - p. 1669 341. FUROSEMIDE STIMULATION TEST - p. 1669 342. GAMMA-GLUTAMYL TRANSFERASE (GGT) - p. 1669 343. GASTRIN (SERUM) - p. 1669 344. GASTRIN STIMULATION TEST - p. 1669 345. GLIADIN ANTIBODIES, IGA AND IGG - p. 1669 346. GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY - p. 1669 347. GLOMERULAR FILTRATION RATE - p. 1669 348. GLUCAGON - p. 1669.e1 349. GLUCOSE, FASTING (FBS, FASTING BLOOD SUGAR) - p. 1669.e1 350. GLUCOSE, POSTPRANDIAL - p. 1670 351. GLUCOSE TOLERANCE TEST - p. 1670 352. GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) SCREEN (BLOOD) - p. 1670 353. γ-GLUTAMYL TRANSFERASE (GGT) - p. 1670 354. GLYCOHEMOGLOBIN (GLYCATED GLYCOSYLATED HEMOGLOBIN), (HBA1C) - p. 1670 355. GROWTH HORMONE - p. 1670.e1 356. GROWTH HORMONE–RELEASING HORMONE (GHRH) - p. 1670.e1 357. GROWTH HORMONE SUPPRESSION TEST (AFTER GLUCOSE) - p. 1670.e1 358. HAM TEST (ACID SERUM TEST) - p. 1670.e1 359. HAPTOGLOBIN (SERUM) - p. 1670.e1 360. HBA1c - p. 1670.e1 361. HDL - p. 1670.e1 362. HELICOBACTER PYLORI (SEROLOGY, STOOL ANTIGEN) - p. 1670.e1 363. HEMATOCRIT - p. 1670.e1 364. HEMOGLOBIN - p. 1670.e1 365. HEMOGLOBIN A1C - p. 1670.e1 366. HEMOGLOBIN ELECTROPHORESIS - p. 1670.e1 367. HEMOGLOBIN, GLYCATED - p. 1671 368. HEMOGLOBIN, GLYCOSYLATED - p. 1671 369. HEMOGLOBIN H - p. 1671 370. HEMOGLOBIN, URINE - p. 1671 371. HEMOSIDERIN, URINE - p. 1671 372. HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES - p. 1671 373. HEPATITIS A ANTIBODY - p. 1671 374. HEPATITIS A VIRUS-IGM ANTIBODY - p. 1671.e1 375. HEPATITIS A VIRUS TOTAL ANTIBODY - p. 1671.e1 376. HEPATITIS B SURFACE ANTIGEN (HBSAG) - p. 1671.e1 377. HEPATITIS B VIRAL INFECTION - p. 1671.e1 378. HEPATITIS C RNA - p. 1672 379. HEPATITIS C VIRAL INFECTION - p. 1672 380. HEPATITIS D VIRAL INFECTION - p. 1673 381. HEPATITIS DELTA COINFECTION (ACUTE HDV1 ACUTE HBV) OR SUPERINFECTION (ACUTE HDV1 CHRONIC HBV) - p. 1673 382. HEPATITIS D VIRUS-AB (IGM) - p. 1673 383. HEPATITIS D VIRUS-AG - p. 1673 384. HEPATITIS D VIRUS-AB (TOTAL) - p. 1673 385. HER-2/NEU - p. 1673 386. HERPES SIMPLEX VIRUS (HSV) - p. 1673 387. HETEROPHIL ANTIBODY - p. 1673 388. HFE SCREEN FOR HEREDITARY HEMOCHROMATOSIS - p. 1673 389. HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL - p. 1673 390. HLA ANTIGENS - p. 1674.e1 391. HOMOCYSTEINE (PLASMA) - p. 1674.e1 392. HUMAN CHORIONIC GONADOTROPIN (HCG) - p. 1674.e1 393. HUMAN HERPES VIRUS 8 (HHV8) - p. 1674.e1 394. HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY, TYPE 1 (HIV-1) - p. 1674.e1 395. HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) ANTIGEN (P24), QUALITATIVE (P24 ANTIGEN) - p. 1675 396. HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) VIRAL LOAD - p. 1675 397. HUMAN PAPILLOMAVIRUS (HPV) - p. 1675 398. HUNTINGTON DISEASE PCR - p. 1675 399. HYDROGEN BREATH TEST - p. 1675 400. 5-HYDROXYINDOLE-ACETIC ACID, URINE - p. 1675 401. IMMUNE COMPLEX ASSAY - p. 1675 402. IMMUNOGLOBULINS - p. 1675 403. INDIRECT ANTIGLOBULIN (COOMBS INDIRECT) - p. 1675.e2 404. INFLUENZA A AND B TESTS - p. 1675.e2 405. INSULIN AUTOANTIBODIES - p. 1675.e2 406. INSULIN, FREE - p. 1676 407. INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) (SERUM) - p. 1676 408. INSULIN-LIKE GROWTH FACTOR-II - p. 1676 409. INTERNATIONAL NORMALIZED RATIO (INR) - p. 1676 410. INTRINSIC FACTOR ANTIBODIES - p. 1676 411. IRON (SERUM) - p. 1676 412. IRON-BINDING CAPACITY, TOTAL (TIBC) - p. 1676 413. IRON SATURATION (% TRANSFERRIN SATURATION) - p. 1676.e1 414. LACTATE (BLOOD) - p. 1676.e1 415. LACTATE DEHYDROGENASE (LDH) - p. 1676.e1 416. LACTATE DEHYDROGENASE ISOENZYMES - p. 1676.e1 417. LACTOSE TOLERANCE TEST (SERUM) - p. 1676.e1 418. LAP SCORE - p. 1676.e1 419. LEAD - p. 1677 420. LDH - p. 1677 421. LDL - p. 1677 422. LEGIONELLA PNEUMOPHILA PCR - p. 1677 423. LEGIONELLA TITER - p. 1677 424. LEUKOCYTE ALKALINE PHOSPHATASE (LAP) - p. 1677 425. LEUKOCYTE COUNT - p. 1677 426. LIPASE - p. 1677 427. LIPOPROTEIN(A) - p. 1677 428. LIPOPROTEIN CHOLESTEROL, HIGH-DENSITY - p. 1677.e1 429. LIPOPROTEIN CHOLESTEROL, LOW-DENSITY - p. 1677.e1 430. LIVER KIDNEY MICROSOME TYPE 1 ANTIBODIES (LKM1) - p. 1677.e1 431. LKM1 - p. 1677.e1 432. LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL - p. 1677.e1 433. LUPUS ANTICOAGULANT - p. 1677.e2 434. LUTEINIZING HORMONE - p. 1677.e2 435. LYME DISEASE ANTIBODY TITER - p. 1677.e4 436. LYMPHOCYTES - p. 1677.e4 437. MAGNESIUM (SERUM) - p. 1677.e5 438. MEAN CORPUSCULAR VOLUME (MCV) - p. 1678 439. METANEPHRINES, URINE - p. 1678.e2 440. METHYLMALONIC ACID (SERUM) - p. 1678.e2 441. MITOCHONDRIAL ANTIBODY (AMA) - p. 1678.e2 442. MONOCYTE COUNT - p. 1678.e2 443. MYCOPLASMA PNEUMONIAE PCR - p. 1678.e3 444. MYELIN BASIC PROTEIN, CEREBROSPINAL FLUID - p. 1678.e3 445. MYOGLOBIN, URINE - p. 1678.e3 446. NEISSERIA GONORRHOEAE PCR - p. 1678.e3 447. NEUTROPHIL COUNT - p. 1678.e3 448. NOREPINEPHRINE - p. 1678.e4 449. 5′-NUCLEOTIDASE - p. 1678.e4 450. OSMOLALITY (SERUM) - p. 1679 451. OSMOLALITY, URINE - p. 1679.e1 452. OSMOTIC FRAGILITY TEST - p. 1679.e2 453. PARACENTESIS FLUID - p. 1679.e2 454. PARATHYROID HORMONE (PTH) - p. 1679.e2 455. PARIETAL CELL ANTIBODIES - p. 1679.e3 456. PARTIAL THROMBOPLASTIN TIME (PTT), ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) - p. 1679.e3 457. PEPSINOGEN I - p. 1679.e3 458. PH, BLOOD - p. 1679.e3 459. Ph, Urine - p. 1679.e3 460. PHENOBARBITAL - p. 1679.e3 461. PHENYTOIN (DILANTIN) - p. 1679.e3 462. PHOSPHATASE, ACID - p. 1680 463. PHOSPHATASE, ALKALINE - p. 1680 464. PHOSPHATE (SERUM) - p. 1680 465. PLASMA CELLS - p. 1680.e1 466. PLASMINOGEN - p. 1680.e1 467. PLATELET AGGREGATION - p. 1680.e1 468. PLATELET ANTIBODIES - p. 1680.e1 469. PLATELET COUNT - p. 1680.e1 470. PLATELET FUNCTION ANALYSIS 100 ASSAY (PFA) - p. 1681.e1 471. PLEURAL FLUID - p. 1681.e1 472. POTASSIUM (SERUM) - p. 1681.e1 473. POTASSIUM, URINE - p. 1682 474. PROCAINAMIDE - p. 1683 475. PROGESTERONE (SERUM) - p. 1683 476. PROLACTIN - p. 1683 477. PROSTATE-SPECIFIC ANTIGEN (PSA) - p. 1683.e1 478. PROSTATIC ACID PHOSPHATASE - p. 1683.e1 479. PROTEIN (SERUM) - p. 1683.e1 480. PROTEIN C ASSAY - p. 1683.e1 481. PROTEIN ELECTROPHORESIS (SERUM) - p. 1683.e1 482. PROTEIN S ASSAY - p. 1683.e2 483. PROTHROMBIN TIME (PT) - p. 1683.e3 484. PROTOPORPHYRIN (FREE ERYTHROCYTE) - p. 1684.e1 485. PSA - p. 1684.e1 486. PT - p. 1684.e1 487. PTH - p. 1684.e1 488. PTT - p. 1684.e1 489. RAPID PLASMA REAGIN (RPR) - p. 1684.e1 490. RDW - p. 1684.e1 491. RED BLOOD CELL (RBC) COUNT - p. 1684.e1 492. RED BLOOD CELL DISTRIBUTION WIDTH (RDW) - p. 1684.e1 493. RED BLOOD CELL FOLATE - p. 1684.e1 494. RED BLOOD CELL MASS (VOLUME) - p. 1684.e1 495. RED BLOOD CELL MORPHOLOGY - p. 1684.e1 496. RENIN (SERUM) - p. 1684.e3 497. RESPIRATORY SYNCYTIAL VIRUS (RSV) SCREEN - p. 1684.e4 498. RETICULOCYTE COUNT - p. 1684.e4 499. RHEUMATOID FACTOR - p. 1685 500. RPR - p. 1685 501. ROTAVIRUS SEROLOGY - p. 1685 502. SARS-COV-2 ANTIBODIES - p. 1685 503. SED RATE - p. 1685 504. SEDIMENTATION RATE - p. 1685 505. SEMEN ANALYSIS - p. 1685 506. SGOT - p. 1685 507. SGPT - p. 1685 508. SICKLE CELL TEST - p. 1685 509. SMOOTH MUSCLE ANTIBODY - p. 1685 510. SODIUM (SERUM) - p. 1685 511. STREPTOZYME - p. 1686.e1 512. SUCROSE HEMOLYSIS TEST (SUGAR WATER TEST) - p. 1686.e1 513. SUDAN III STAIN (QUALITATIVE SCREENING FOR FECAL FAT) - p. 1686.e1 514. SYNOVIAL FLUID ANALYSIS - p. 1686.e1 515. T3 (TRIIODOTHYRONINE) - p. 1686.e2 516. T3 RESIN UPTAKE (T3RU) - p. 1686.e2 517. T4, FREE (FREE THYROXINE) - p. 1686.e2 518. T4, SERUM T4 - p. 1686.e2 519. TEGRETOL - p. 1687.e1 520. TESTOSTERONE (TOTAL TESTOSTERONE) - p. 1687.e1 521. THEOPHYLLINE - p. 1687.e1 522. THORACENTESIS FLUID - p. 1687.e1 523. THROMBIN TIME (TT), THROMBIN CLOTTING TIME (TCT) - p. 1687.e1 524. THYROGLOBULIN - p. 1687.e1 525. THYROID MICROSOMAL ANTIBODIES - p. 1687.e1 526. THYROID-STIMULATING HORMONE (TSH) - p. 1687.e1 527. THYROTROPIN (TSH) RECEPTOR ANTIBODIES - p. 1688 528. THYROTROPIN-RELEASING HORMONE (TRH) STIMULATION TEST - p. 1688 529. THYROXINE (T4) - p. 1688 530. TIBC - p. 1688 531. TISSUE TRANSGLUTAMINASE ANTIBODY - p. 1688 532. TRANSFERRIN - p. 1688 533. TRIGLYCERIDES - p. 1688 534. TRIIODOTHYRONINE - p. 1688 535. TROPONINS (SERUM) - p. 1688 536. TSH - p. 1688.e1 537. TT - p. 1688.e1 538. TUBERCULIN TEST (PPD) - p. 1688.e1 539. UNCONJUGATED BILIRUBIN - p. 1688.e1 540. UREA NITROGEN, BLOOD (BUN) - p. 1689 541. URIC ACID (SERUM) - p. 1689.e1 542. URINALYSIS - p. 1689.e1 543. URINE AMYLASE - p. 1689.e2 544. URINE BILE - p. 1689.e2 545. URINE CALCIUM - p. 1689.e2 546. URINE CAMP - p. 1689.e2 547. URINE CATECHOLAMINES - p. 1689.e2 548. URINE CHLORIDE - p. 1689.e2 549. URINE COPPER - p. 1689.e2 550. URINE CORTISOL, FREE - p. 1689.e2 551. URINE CREATININE (24 H) - p. 1689.e2 552. URINE CRYSTALS - p. 1689.e2 553. URINE EOSINOPHILS - p. 1689.e2 554. URINE GLUCOSE (QUALITATIVE) - p. 1689.e2 555. URINE HEMOGLOBIN, FREE - p. 1689.e2 556. URINE HEMOSIDERIN - p. 1689.e2 557. URINE 5-HYDROXYINDOLE-ACETIC ACID (URINE 5-HIAA) - p. 1689.e2 558. URINE INDICAN - p. 1690.e1 559. URINE KETONES (SEMIQUANTITATIVE) - p. 1690.e1 560. URINE METANEPHRINES - p. 1690.e1 561. URINE MYOGLOBIN - p. 1690.e1 562. URINE NITRITE - p. 1690.e1 563. URINE OCCULT BLOOD - p. 1690.e1 564. URINE OSMOLALITY - p. 1690.e1 565. URINE PH - p. 1690.e1 566. URINE PHOSPHATE - p. 1690.e1 567. URINE POTASSIUM - p. 1690.e1 568. URINE PROTEIN (QUANTITATIVE) - p. 1690.e1 569. URINE SEDIMENT - p. 1690.e1 570. URINE SODIUM (QUANTITATIVE) - p. 1690.e2 571. URINE SPECIFIC GRAVITY - p. 1691 572. URINE VANILLYLMANDELIC ACID (VMA) - p. 1691 573. VARICELLA-ZOSTER VIRUS (VZV) SEROLOGY - p. 1691 574. VASOACTIVE INTESTINAL PEPTIDE (VIP) - p. 1691 575. VDRL - p. 1691 576. VISCOSITY (SERUM) - p. 1691.e1 577. VITAMIN B12 (COBALAMIN) - p. 1691.e1 578. VITAMIN D, 1,25 DIHYDROXY CALCIFEROL - p. 1691.e2 579. VITAMIN K - p. 1691.e2 580. VON WILLEBRAND FACTOR - p. 1691.e2 581. SECTION V. Clinical Practice Guidelines - p. 1693 582. Introduction - p. 1694 583. CLINICAL PRACTICE GUIDELINES—IMMUNIZATIONS AND CHEMOPROPHYLAXIS - p. 1695 584. Appendix - p. 1736.e1 585. Appendix Ia. Definitions of Complementary and Alternative Medicine Terms - p. 1736.e3 586. Appendix Ib. Relaxation Techniques - p. 1736.e5 587. Appendix Ic. Overview of Selected Natural Products - p. 1736.e7 588. Appendix Id. Natural Products and Drug Interactions - p. 1736.e10 589. Appendix Ie. Commonly Ingested Plants with Significant Toxic Potential - p. 1736.e14 590. Appendix If. Herbs Associated with Toxicity - p. 1736.e15 591. Appendix Ig. Websites Providing Data on Herbal Therapy Hazards - p. 1736.e17 592. Appendix Ih. Common Herbs in Integrated Medicine - p. 1736.e18 593. Appendix Ii. Herbal Activities Against Pain and Chronic Diseases - p. 1736.e23 594. Appendix IIa. Dietary Supplements: What Every Primary Care Provider Should Know - p. 1736.e26 595. Appendix IIb. Vitamins and Their Functions - p. 1736.e28 596. Appendix IIc. Nutritional Trace Elements and Their Clinical Implications - p. 1736.e33 597. Appendix IId. Summary of Vitamin and Mineral Deficiencies - p. 1736.e36 598. Appendix IIIa. Selected Historical and Physical Findings in Poisoning - p. 1736.e38 599. Appendix IIIb. Toxidromes - p. 1736.e40 600. Appendix IIIc. Antidotes and Indications for Use - p. 1736.e42 601. Appendix IIId. Management of Acute Poisoning - p. 1736.e47 602. Appendix IIIe. Pathophysiology, Clinical Effects, and Management of Specific Drugs and Toxicants - p. 1736.e50 603. Appendix IIIf. Accidental Poisoning by Exposure to Other Drugs Acting on the Autonomic Nervous System - p. 1736.e54 604. Appendix IV. Impairment and Disability Issues - p. 1736.e56 605. Appendix V. Protection of Travelers - p. 1736.e58 606. Appendix VI. Care of the Transgender Patient - p. 1736.e68 607. Appendix VIII. Palliative Care - p. 1736.e74 608. Appendix IX. Preoperative Evaluation - p. 1736.e79 609. Index - p. 1737 610. End sheet - p. ES3
**Selected for 2025 Doody’s Core Titles® in Family Medicine**
For nearly 30 years Ferri’s Clinical Advisor has provided immediate answers on the myriad medical diseases and disorders you’re likely to encounter in a unique, easy-to-use format. A bestselling title year after year, this popular "5 books in 1" reference delivers vast amounts of information in a user-friendly manner. It is updated annually to provide current and clinically relevant answers on over 1,000 common medical conditions across sections focusing on diseases and disorders, differential diagnoses, clinical algorithms, laboratory tests, and clinical practice guidelines―all carefully reviewed by experts in key clinical fields. Extensive algorithms, along with hundreds of high-quality photographs, illustrations, diagrams, and tables, ensure that you stay current with today's medical practice.
1. Introduction - p. 1458 2. Clinical Algorithms - p. 1459 3. ABDOMINAL ABSCESS - p. 1459 4. ABDOMINAL PAIN, ACUTE - p. 1461 5. ABDOMINAL PAIN, RIGHT UPPER QUADRANT - p. 1470 6. ACID-BASE HOMEOSTASIS - p. 1471 7. ACIDOSIS, METABOLIC - p. 1474 8. ACIDOSIS, RESPIRATORY, ACUTE - p. 1477 9. ACIDOSIS, RESPIRATORY, CHRONIC - p. 1478 10. AIRWAY OBSTRUCTION, MALIGNANT - p. 1480 11. ALKALOSIS, METABOLIC - p. 1480.e1 12. ALKALOSIS, RESPIRATORY TREATMENT - p. 1482 13. ALLERGIC REACTION TO VACCINES - p. 1483 14. ALTERED MENTAL STATUS AND COMA - p. 1483.e1 15. ALVEOLAR FILLING DISORDERS - p. 1484 16. ALVEOLAR HEMORRHAGE - p. 1484.e1 17. AMBIGUOUS GENITALIA - p. 1484.e3 18. ANEMIA - p. 1484.e5 19. ANEMIA, MACROCYTIC - p. 1486 20. ANEMIA, MICROCYTIC - p. 1487 21. ANISOCORIA - p. 1489 22. ANORECTAL COMPLAINTS - p. 1490.e1 23. AZOOSPERMIA - p. 1492 24. BACK PAIN - p. 1492.e1 25. BLEEDING AND BRUISING PROBLEMS - p. 1498 26. BLEEDING DISORDERS - p. 1502 27. BLEEDING, PATIENT ON DABIGATRAN - p. 1503 28. BLEEDING, PATIENT ON ORAL FACTOR XA INHIBITORS - p. 1503.e2 29. BRADYCARDIA - p. 1503.e4 30. BREAST LUMP - p. 1504 31. BULLAE ON LOWER EXTREMITIES - p. 1505 32. CAFÉ-AU-LAIT MACULES - p. 1505.e1 33. CARDIAC ARREST - p. 1505.e3 34. CARDIOGENIC SHOCK - p. 1509 35. CARDIOMEGALY ON CHEST X-RAY EXAMINATION - p. 1509.e1 36. CARDIOMYOPATHY - p. 1512 37. CAUSTIC INGESTION - p. 1514 38. CHEST PAIN - p. 1514.e1 39. CENTRAL NERVOUS SYSTEM INFECTION, PRESUMED - p. 1517 40. CONFUSION - p. 1518 41. CONNECTIVE TISSUE DISORDER, SUSPECTED - p. 1521 42. CONNECTIVE TISSUE LABORATORY TESTS - p. 1522 43. CONVULSIVE DISORDER, SUSPECTED, PEDIATRIC PATIENT - p. 1524 44. COUGH, CHRONIC - p. 1524.e1 45. CYSTITIS, ACUTE - p. 1528 46. DAYTIME SLEEPINESS, PEDIATRIC PATIENT - p. 1528.e1 47. DEFECATION DISORDER, PEDIATRIC AGE - p. 1528.e2 48. DIARRHEA, ACUTE - p. 1528.e3 49. DIARRHEA, WATERY - p. 1531 50. DILATED PUPIL - p. 1531.e1 51. DYSPNEA - p. 1531.e2 52. EDEMA - p. 1535 53. EPILEPSY - p. 1536 54. ERYTHROCYTOSIS, ACQUIRED - p. 1536.e2 55. ESOPHAGEAL FOREIGN BODY - p. 1537 56. ESOPHAGEAL PERFORATION - p. 1537.e2 57. EXANTHEMATOUS DRUG REACTION - p. 1537.e4 58. FEVER AND INFECTION IN HIGH-RISK HEMATOLOGY PATIENT WITHOUT OBVIOUS SOURCE - p. 1539 59. FEVER AND NEUTROPENIA - p. 1539.e1 60. FEVER AND NEUTROPENIA, PEDIATRIC PATIENT - p. 1543 61. FEVER AND RASH - p. 1543.e1 62. GASTROINTESTINAL BLEEDING - p. 1544 63. GASTROINTESTINAL FISTULA - p. 1549 64. GOITER EVALUATION AND MANAGEMENT - p. 1549.e1 65. GRANULOMA, NONINFECTIOUS - p. 1549.e2 66. HEADACHE - p. 1549.e4 67. HEARING LOSS - p. 1554 68. HEMATOCHEZIA, MANAGEMENT - p. 1561 69. HEMATURIA, PEDIATRIC PATIENT - p. 1561.e1 70. HEPATIC MASS - p. 1563 71. HEPATOMEGALY - p. 1564 72. HYPERCALCEMIA - p. 1566 73. HYPERCAPNIA - p. 1569 74. HYPERPIGMENTATION - p. 1570 75. HYPOTENSION - p. 1570.e3 76. HYPOTENSION, POSTOPERATIVE - p. 1571 77. HYPOVOLEMIC SHOCK - p. 1571.e1 78. HYPOXEMIA - p. 1571.e2 79. HYPOXEMIA, POSTOPERATIVE - p. 1572 80. INFECTIONS OF SOFT TISSUE, JOINTS, AND BONE - p. 1572.e1 81. INTRAABDOMINAL INFECTION, SUSPECTED - p. 1573 82. JOINT EFFUSION - p. 1574 83. JOINT PAIN AND SWELLING - p. 1575 84. LEG ULCERS - p. 1579 85. LIMB ISCHEMIA, ACUTE - p. 1580 86. LIVER FUNCTION TEST ELEVATIONS - p. 1581 87. LIVER MASS - p. 1582.e1 88. MEDIASTINAL MASS - p. 1583 89. MENTAL STATUS CHANGE, ELDERLY PATIENT - p. 1585 90. MUSCULOSKELETAL COMPLAINTS - p. 1586 91. MUSCULOSKELETAL PAIN, CHRONIC - p. 1587 92. NAUSEA AND VOMITING - p. 1589 93. NECK MASS - p. 1595 94. NECK PAIN - p. 1596 95. OLIGURIA - p. 1600 96. OTALGIA AND OTORRHEA - p. 1602 97. PALPITATIONS, DIZZINESS, AND/OR SYNCOPE - p. 1603 98. PANCREATIC ISLET CELL TUMORS - p. 1604 99. PANCREATIC MASS - p. 1604.e2 100. PELVIC PAIN, WOMEN, DIAGNOSTIC EVALUATION - p. 1605 101. PELVIC PAIN, WOMEN, MANAGEMENT - p. 1607 102. PERIPHERAL NEUROPATHY - p. 1608 103. PHOTOSENSITIVITY - p. 1612 104. PLEURAL INFECTION - p. 1612.e1 105. PNEUMOTHORAX, TRAUMATIC - p. 1614 106. POLYURIA - p. 1615 107. PREMATURE VENTRICULAR COMPLEXES - p. 1616 108. PROTEINURIA IN CHILDREN - p. 1616.e1 109. PRURITUS IN PREGNANT WOMAN - p. 1616.e2 110. PULMONARY NODULE - p. 1616.e3 111. PURPURA - p. 1620 112. RASH, ACUTE GENERALIZED SKIN ERUPTION - p. 1620.e1 113. RECTAL ULCER - p. 1620.e2 114. RED AND PAINFUL EYE - p. 1620.e3 115. RED EYE - p. 1621 116. RENAL MASS - p. 1621.e3 117. RENAL TRAUMA - p. 1622.e1 118. RHINITIS - p. 1622.e2 119. SCROTAL MASS - p. 1622.e3 120. SEIZURES, NEWBORN - p. 1623 121. SHOCK - p. 1623.e2 122. SHORT STATURE - p. 1623.e7 123. SHOULDER PAIN - p. 1623.e8 124. SKIN AND SOFT TISSUE INFECTIONS - p. 1623.e12 125. SLEEP DISORDERS ASSOCIATED WITH PREGNANCY - p. 1623.e15 126. SLEEP DISORDERS NOT CHARACTERIZED BY HYPERSOMNIA - p. 1623.e16 127. SLEEP-RELATED MOVEMENT DISORDERS - p. 1623.e17 128. SORE THROAT - p. 1624 129. SPINAL METASTATIC DISEASE - p. 1626 130. SPLENIC INJURY - p. 1626.e2 131. TACHYCARDIA, DIAGNOSTIC APPROACH - p. 1626.e4 132. TACHYCARDIA, NARROW COMPLEX - p. 1628 133. TACHYCARDIA, PEDIATRIC PATIENT - p. 1629 134. TACHYCARDIA, WIDE QRS - p. 1629.e1 135. TESTICULAR MASS - p. 1630 136. THROMBOTIC MICROANGIOPATHIES, DIFFERENTIAL DIAGNOSIS - p. 1631 137. TRAUMA IN PREGNANCY - p. 1631.e1 138. TRAUMATIC AORTIC INJURY - p. 1631.e2 139. URETHRAL DISCHARGE OR DYSURIA - p. 1631.e3 140. URINARY SYMPTOMS, LOWER URINARY TRACT - p. 1632 141. URINARY TRACT OBSTRUCTION - p. 1634 142. VAGINAL DISCHARGE, EVALUATION - p. 1635 143. VAGINITIS, PEDIATRIC - p. 1636 144. VENTILATOR-ASSOCIATED PNEUMONIA - p. 1637 145. VENTRICULAR FIBRILLATION OR PULSELESS VENTRICULAR TACHYCARDIA - p. 1637.e1 146. VERTIGO - p. 1637.e2 147. VIRAL EXANTHEM - p. 1640 148. VOMITING, ACUTE, MANAGEMENT - p. 1640.e1 149. WEAKNESS - p. 1640.e3 150. WEIGHT LOSS, UNINTENTIONAL - p. 1645 151. SECTION IV. Laboratory Tests and Interpretation of Results - p. 1649 152. Introduction - p. 1650 153. Laboratory Tests and Interpretation of Results - p. 1650 154. ACE LEVEL - p. 1650 155. ACETONE (SERUM OR PLASMA) - p. 1651 156. ACETYLCHOLINE RECEPTOR (AChR) ANTIBODY - p. 1651 157. ACID-BASE REFERENCE VALUES - p. 1651 158. ACID PHOSPHATASE (SERUM) - p. 1651 159. ACID SERUM TEST - p. 1651 160. ACTIVATED CLOTTING TIME (ACT) - p. 1651 161. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT, aPTT) - p. 1651 162. ADRENOCORTICOTROPIC HORMONE (ACTH) - p. 1651 163. ALANINE AMINOPEPTIDASE - p. 1651.e1 164. ALANINE AMINOTRANSFERASE (ALT, SGPT) - p. 1651.e1 165. ALBUMIN (SERUM) - p. 1651.e3 166. ALCOHOL DEHYDROGENASE - p. 1652 167. ALDOLASE (SERUM) - p. 1652 168. ALDOSTERONE - p. 1653 169. ALKALINE PHOSPHATASE (ALP) (SERUM) - p. 1653.e1 170. ALPHA-1-ANTITRYPSIN (SERUM) - p. 1653.e3 171. ALPHA-1-FETOPROTEIN (SERUM) - p. 1653.e3 172. ALT - p. 1653.e3 173. ALUMINUM (SERUM) - p. 1653.e3 174. AMA - p. 1653.e3 175. AMEBIASIS SEROLOGIC TEST - p. 1653.e3 176. AMINOLEVULINIC ACID (δ-ALA) (24-H URINE COLLECTION) - p. 1653.e3 177. AMMONIA (SERUM) - p. 1653.e3 178. AMYLASE (SERUM) - p. 1653.e4 179. AMYLASE, URINE - p. 1653.e5 180. AMYLOID A PROTEIN (SERUM) - p. 1653.e5 181. ANA - p. 1653.e5 182. ANCA - p. 1653.e5 183. ANDROSTENEDIONE (SERUM) - p. 1653.e5 184. ANGIOTENSIN II - p. 1653.e5 185. ANGIOTENSIN-CONVERTING ENZYME (ACE LEVEL) - p. 1653.e5 186. ANH - p. 1654 187. ANION GAP (AG) - p. 1654 188. ANTICARDIOLIPIN ANTIBODY (ACA) - p. 1654.e1 189. ANTICOAGULANT - p. 1654.e1 190. ANTIDIURETIC HORMONE - p. 1654.e1 191. ANTI-DNA - p. 1654.e3 192. ANTI-DS DNA - p. 1654.e3 193. ANTIGLOBULIN TEST - p. 1654.e3 194. ANTIGLOMERULAR BASEMENT ANTIBODY - p. 1654.e3 195. ANTIHISTONE - p. 1654.e3 196. ANTIMITOCHONDRIAL ANTIBODY (AMA, MITOCHONDRIAL ANTIBODY) - p. 1654.e3 197. ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) - p. 1654.e3 198. ANTINUCLEAR ANTIBODY (ANA) - p. 1654.e4 199. ANTI-RNP ANTIBODY - p. 1654.e7 200. ANTI-SCL-70 - p. 1654.e7 201. ANTI-SM (ANTI-SMITH) ANTIBODY - p. 1654.e7 202. ANTI-SMOOTH MUSCLE ANTIBODY - p. 1654.e7 203. ANTISTREPTOLYSIN O TITER (STREPTOZYME, ASLO TITER) - p. 1654.e7 204. ANTITHROMBIN III - p. 1655 205. APOLIPOPROTEIN A-1 (APO A-1) - p. 1655.e1 206. APOLIPOPROTEIN B (APO B) - p. 1655.e1 207. ARTERIAL BLOOD GASES - p. 1655.e1 208. ARTHROCENTESIS FLUID - p. 1655.e1 209. ASO TITER - p. 1655.e2 210. ASPARTATE AMINOTRANSFERASE (AST, SGOT) - p. 1655.e2 211. ATRIAL NATRIURETIC HORMONE (ANH) - p. 1656.e1 212. B-TYPE NATRIURETIC PEPTIDE (BNP) - p. 1656.e1 213. BASOPHIL COUNT - p. 1657 214. BICARBONATE - p. 1657 215. BILE, URINE - p. 1657 216. BILIRUBIN, DIRECT (CONJUGATED BILIRUBIN) - p. 1657 217. BILIRUBIN, INDIRECT (UNCONJUGATED BILIRUBIN) - p. 1657 218. BILIRUBIN, TOTAL - p. 1657 219. BILIRUBIN, URINE - p. 1657.e2 220. BLADDER TUMOR ASSOCIATED ANTIGEN - p. 1657.e2 221. BLEEDING TIME (MODIFIED IVY METHOD) - p. 1657.e2 222. BLOOD TYPE - p. 1657.e3 223. BLOOD VOLUME, TOTAL - p. 1657.e3 224. BNP - p. 1657.e3 225. BORDETELLA PERTUSSIS SEROLOGY - p. 1657.e3 226. BRCA ANALYSIS - p. 1657.e3 227. BREATH HYDROGEN TEST (HYDROGEN BREATH TEST) - p. 1658 228. BUN - p. 1658 229. C282Y AND H63D MUTATION ANALYSIS - p. 1658 230. C3 - p. 1658 231. C4 - p. 1658 232. CALCITONIN (SERUM) - p. 1658 233. CALCIUM (SERUM) - p. 1658 234. CALCIUM, URINE - p. 1658.e4 235. CANCER ANTIGEN 15-3 (CA 15-3) - p. 1659 236. CANCER ANTIGEN 27-29 (CA 27-29) - p. 1659 237. CANCER ANTIGEN 72-4 (CA 72-4) - p. 1659 238. CANCER ANTIGEN 125 (CA 125) - p. 1659 239. CAPTOPRIL STIMULATION TEST - p. 1659 240. CARBAMAZEPINE (TEGRETOL) - p. 1659 241. CARBAMAZEPINE LEVEL - p. 1659 242. CARBOHYDRATE ANTIGEN 19-9 - p. 1659 243. CARBON DIOXIDE, PARTIAL PRESSURE - p. 1659 244. CARBON MONOXIDE - p. 1659 245. CARBOXYHEMOGLOBIN - p. 1659 246. CARCINOEMBRYONIC ANTIGEN (CEA) - p. 1659 247. CAROTENE (SERUM) - p. 1660 248. CATECHOLAMINES, URINE - p. 1660 249. CBC - p. 1660 250. CD40 LIGAND - p. 1660 251. CEA - p. 1660.e1 252. CEREBROSPINAL FLUID (CSF) - p. 1660.e1 253. CERULOPLASMIN (SERUM) - p. 1661.e3 254. CHLAMYDIA GROUP ANTIBODY SEROLOGIC TEST - p. 1661.e3 255. CHLAMYDIA TRACHOMATIS PCR - p. 1661.e3 256. CHLORIDE (SERUM) - p. 1661.e3 257. CHLORIDE (SWEAT) - p. 1662 258. CHLORIDE, URINE - p. 1662 259. CHOLECYSTOKININ-PANCREOZYMIN (CCK, CCK-PZ) - p. 1662 260. CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN - p. 1662 261. CHOLESTEROL, LOW-DENSITY LIPOPROTEIN - p. 1662 262. CHOLESTEROL, TOTAL - p. 1662 263. CHORIONIC GONADOTROPINS, HUMAN (SERUM) (hCG) - p. 1662.e1 264. CHYMOTRYPSIN - p. 1662.e1 265. CIRCULATING ANTICOAGULANT (LUPUS ANTICOAGULANT) - p. 1662.e1 266. CK - p. 1662.e1 267. CLONIDINE SUPPRESSION TEST - p. 1662.e1 268. CLOSTRIDIUM DIFFICILE TOXIN ASSAY (STOOL) - p. 1662.e1 269. Co - p. 1662.e1 270. COAGULATION FACTORS - p. 1662.e1 271. COBALAMIN, SERUM - p. 1663.e1 272. COLD AGGLUTININS TITER - p. 1663.e1 273. COMPLEMENT - p. 1663.e1 274. COMPLETE BLOOD COUNT (CBC) - p. 1663.e2 275. CONJUGATED BILIRUBIN - p. 1663.e3 276. COPPER (SERUM) - p. 1663.e3 277. COPPER, URINE - p. 1663.e3 278. CORTICOTROPIN RELEASING HORMONE (CRH) STIMULATION TEST - p. 1663.e3 279. CORTISOL, PLASMA - p. 1663.e3 280. COOMBS DIRECT - p. 1663.e3 281. COOMBS INDIRECT - p. 1663.e3 282. COVID-19 - p. 1663.e3 283. C-PEPTIDE - p. 1663.e3 284. CPK - p. 1663.e3 285. C-REACTIVE PROTEIN - p. 1663.e3 286. C-REACTIVE PROTEIN, HIGH SENSITIVITY (hs-CRP, CARDIO-CRP) - p. 1665 287. CREATINE KINASE (CK, CPK) - p. 1665 288. CREATINE KINASE ISOENZYMES - p. 1665.e2 289. CREATININE (SERUM) - p. 1665.e2 290. CREATININE CLEARANCE - p. 1665.e3 291. CREATININE, URINE - p. 1665.e3 292. CRYOGLOBULINS (SERUM) - p. 1665.e3 293. CRYPTOSPORIDIUM ANTIGEN BY EIA (STOOL) - p. 1665.e3 294. CSF - p. 1665.e3 295. CYSTATIN C - p. 1665.e3 296. CYSTIC FIBROSIS PCR - p. 1665.e3 297. CYTOMEGALOVIRUS BY PCR - p. 1665.e3 298. d-DIMER - p. 1665.e3 299. DEHYDROEPIANDROSTERONE SULFATE - p. 1666 300. DEOXYCORTICOSTERONE (11-DEOXYCORTICOSTERONE, DOC) (SERUM) - p. 1666 301. DEXAMETHASONE SUPPRESSION TEST, OVERNIGHT - p. 1666 302. DIGOXIN - p. 1666 303. DIGOXIN LEVEL - p. 1666.e1 304. DIHYDROTESTOSTERONE (SERUM, URINE) - p. 1666.e1 305. DILANTIN - p. 1666.e1 306. DIRECT ANTIGLOBULIN (COOMBS DIRECT) - p. 1666.e1 307. DISACCHARIDE ABSORPTION TESTS - p. 1666.e1 308. DOC - p. 1666.e1 309. DONATH-LANDSTEINER (D-L) TEST FOR PAROXYSMAL COLD HEMOGLOBINURIA - p. 1666.e1 310. DOPAMINE - p. 1666.e1 311. D-XYLOSE ABSORPTION - p. 1666.e1 312. D-XYLOSE ABSORPTION TEST - p. 1667 313. ELECTROPHORESIS, HEMOGLOBIN - p. 1667 314. ELECTROPHORESIS, PROTEIN - p. 1667 315. ENA COMPLEX - p. 1667 316. ENDOMYSIAL ANTIBODIES - p. 1667 317. EOSINOPHIL COUNT - p. 1667 318. EPINEPHRINE, PLASMA - p. 1667.e2 319. EPSTEIN-BARR VIRUS SEROLOGY - p. 1667.e2 320. ERYTHROCYTE SEDIMENTATION RATE (ESR, SED RATE, SEDIMENTATION RATE) - p. 1667.e3 321. ERYTHROPOIETIN (EP) - p. 1667.e3 322. ESTRADIOL (SERUM) - p. 1667.e3 323. ESTROGEN - p. 1668 324. ETHANOL (BLOOD) - p. 1668 325. EXTRACTABLE NUCLEAR ANTIGEN (ENA COMPLEX, ANTI-RNP ANTIBODY, ANTI-SM, ANTI-SMITH) - p. 1668.e1 326. FACTOR V LEIDEN - p. 1668.e1 327. FASTING BLOOD SUGAR - p. 1668.e1 328. FBS - p. 1668.e1 329. FDP - p. 1668.e1 330. FECAL FAT, QUANTITATIVE (72-H COLLECTION) - p. 1668.e1 331. FECAL GLOBIN IMMUNOCHEMICAL TEST - p. 1668.e1 332. FERRITIN (SERUM) - p. 1668.e1 333. α-1 FETOPROTEIN - p. 1668.e1 334. FIBRIN DEGRADATION PRODUCT (FDP) - p. 1668.e1 335. FIBRINOGEN - p. 1668.e1 336. FOLATE (FOLIC ACID) - p. 1668.e1 337. FOLLICLE-STIMULATING HORMONE (FSH) - p. 1668.e2 338. FREE T4 - p. 1668.e2 339. FREE THYROXINE INDEX - p. 1668.e2 340. FTA-ABS (SERUM) - p. 1669 341. FUROSEMIDE STIMULATION TEST - p. 1669 342. GAMMA-GLUTAMYL TRANSFERASE (GGT) - p. 1669 343. GASTRIN (SERUM) - p. 1669 344. GASTRIN STIMULATION TEST - p. 1669 345. GLIADIN ANTIBODIES, IGA AND IGG - p. 1669 346. GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY - p. 1669 347. GLOMERULAR FILTRATION RATE - p. 1669 348. GLUCAGON - p. 1669.e1 349. GLUCOSE, FASTING (FBS, FASTING BLOOD SUGAR) - p. 1669.e1 350. GLUCOSE, POSTPRANDIAL - p. 1670 351. GLUCOSE TOLERANCE TEST - p. 1670 352. GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) SCREEN (BLOOD) - p. 1670 353. γ-GLUTAMYL TRANSFERASE (GGT) - p. 1670 354. GLYCOHEMOGLOBIN (GLYCATED GLYCOSYLATED HEMOGLOBIN), (HBA1C) - p. 1670 355. GROWTH HORMONE - p. 1670.e1 356. GROWTH HORMONE–RELEASING HORMONE (GHRH) - p. 1670.e1 357. GROWTH HORMONE SUPPRESSION TEST (AFTER GLUCOSE) - p. 1670.e1 358. HAM TEST (ACID SERUM TEST) - p. 1670.e1 359. HAPTOGLOBIN (SERUM) - p. 1670.e1 360. HBA1c - p. 1670.e1 361. HDL - p. 1670.e1 362. HELICOBACTER PYLORI (SEROLOGY, STOOL ANTIGEN) - p. 1670.e1 363. HEMATOCRIT - p. 1670.e1 364. HEMOGLOBIN - p. 1670.e1 365. HEMOGLOBIN A1C - p. 1670.e1 366. HEMOGLOBIN ELECTROPHORESIS - p. 1670.e1 367. HEMOGLOBIN, GLYCATED - p. 1671 368. HEMOGLOBIN, GLYCOSYLATED - p. 1671 369. HEMOGLOBIN H - p. 1671 370. HEMOGLOBIN, URINE - p. 1671 371. HEMOSIDERIN, URINE - p. 1671 372. HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES - p. 1671 373. HEPATITIS A ANTIBODY - p. 1671 374. HEPATITIS A VIRUS-IGM ANTIBODY - p. 1671.e1 375. HEPATITIS A VIRUS TOTAL ANTIBODY - p. 1671.e1 376. HEPATITIS B SURFACE ANTIGEN (HBSAG) - p. 1671.e1 377. HEPATITIS B VIRAL INFECTION - p. 1671.e1 378. HEPATITIS C RNA - p. 1672 379. HEPATITIS C VIRAL INFECTION - p. 1672 380. HEPATITIS D VIRAL INFECTION - p. 1673 381. HEPATITIS DELTA COINFECTION (ACUTE HDV1 ACUTE HBV) OR SUPERINFECTION (ACUTE HDV1 CHRONIC HBV) - p. 1673 382. HEPATITIS D VIRUS-AB (IGM) - p. 1673 383. HEPATITIS D VIRUS-AG - p. 1673 384. HEPATITIS D VIRUS-AB (TOTAL) - p. 1673 385. HER-2/NEU - p. 1673 386. HERPES SIMPLEX VIRUS (HSV) - p. 1673 387. HETEROPHIL ANTIBODY - p. 1673 388. HFE SCREEN FOR HEREDITARY HEMOCHROMATOSIS - p. 1673 389. HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL - p. 1673 390. HLA ANTIGENS - p. 1674.e1 391. HOMOCYSTEINE (PLASMA) - p. 1674.e1 392. HUMAN CHORIONIC GONADOTROPIN (HCG) - p. 1674.e1 393. HUMAN HERPES VIRUS 8 (HHV8) - p. 1674.e1 394. HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY, TYPE 1 (HIV-1) - p. 1674.e1 395. HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) ANTIGEN (P24), QUALITATIVE (P24 ANTIGEN) - p. 1675 396. HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) VIRAL LOAD - p. 1675 397. HUMAN PAPILLOMAVIRUS (HPV) - p. 1675 398. HUNTINGTON DISEASE PCR - p. 1675 399. HYDROGEN BREATH TEST - p. 1675 400. 5-HYDROXYINDOLE-ACETIC ACID, URINE - p. 1675 401. IMMUNE COMPLEX ASSAY - p. 1675 402. IMMUNOGLOBULINS - p. 1675 403. INDIRECT ANTIGLOBULIN (COOMBS INDIRECT) - p. 1675.e2 404. INFLUENZA A AND B TESTS - p. 1675.e2 405. INSULIN AUTOANTIBODIES - p. 1675.e2 406. INSULIN, FREE - p. 1676 407. INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) (SERUM) - p. 1676 408. INSULIN-LIKE GROWTH FACTOR-II - p. 1676 409. INTERNATIONAL NORMALIZED RATIO (INR) - p. 1676 410. INTRINSIC FACTOR ANTIBODIES - p. 1676 411. IRON (SERUM) - p. 1676 412. IRON-BINDING CAPACITY, TOTAL (TIBC) - p. 1676 413. IRON SATURATION (% TRANSFERRIN SATURATION) - p. 1676.e1 414. LACTATE (BLOOD) - p. 1676.e1 415. LACTATE DEHYDROGENASE (LDH) - p. 1676.e1 416. LACTATE DEHYDROGENASE ISOENZYMES - p. 1676.e1 417. LACTOSE TOLERANCE TEST (SERUM) - p. 1676.e1 418. LAP SCORE - p. 1676.e1 419. LEAD - p. 1677 420. LDH - p. 1677 421. LDL - p. 1677 422. LEGIONELLA PNEUMOPHILA PCR - p. 1677 423. LEGIONELLA TITER - p. 1677 424. LEUKOCYTE ALKALINE PHOSPHATASE (LAP) - p. 1677 425. LEUKOCYTE COUNT - p. 1677 426. LIPASE - p. 1677 427. LIPOPROTEIN(A) - p. 1677 428. LIPOPROTEIN CHOLESTEROL, HIGH-DENSITY - p. 1677.e1 429. LIPOPROTEIN CHOLESTEROL, LOW-DENSITY - p. 1677.e1 430. LIVER KIDNEY MICROSOME TYPE 1 ANTIBODIES (LKM1) - p. 1677.e1 431. LKM1 - p. 1677.e1 432. LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL - p. 1677.e1 433. LUPUS ANTICOAGULANT - p. 1677.e2 434. LUTEINIZING HORMONE - p. 1677.e2 435. LYME DISEASE ANTIBODY TITER - p. 1677.e4 436. LYMPHOCYTES - p. 1677.e4 437. MAGNESIUM (SERUM) - p. 1677.e5 438. MEAN CORPUSCULAR VOLUME (MCV) - p. 1678 439. METANEPHRINES, URINE - p. 1678.e2 440. METHYLMALONIC ACID (SERUM) - p. 1678.e2 441. MITOCHONDRIAL ANTIBODY (AMA) - p. 1678.e2 442. MONOCYTE COUNT - p. 1678.e2 443. MYCOPLASMA PNEUMONIAE PCR - p. 1678.e3 444. MYELIN BASIC PROTEIN, CEREBROSPINAL FLUID - p. 1678.e3 445. MYOGLOBIN, URINE - p. 1678.e3 446. NEISSERIA GONORRHOEAE PCR - p. 1678.e3 447. NEUTROPHIL COUNT - p. 1678.e3 448. NOREPINEPHRINE - p. 1678.e4 449. 5′-NUCLEOTIDASE - p. 1678.e4 450. OSMOLALITY (SERUM) - p. 1679 451. OSMOLALITY, URINE - p. 1679.e1 452. OSMOTIC FRAGILITY TEST - p. 1679.e2 453. PARACENTESIS FLUID - p. 1679.e2 454. PARATHYROID HORMONE (PTH) - p. 1679.e2 455. PARIETAL CELL ANTIBODIES - p. 1679.e3 456. PARTIAL THROMBOPLASTIN TIME (PTT), ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) - p. 1679.e3 457. PEPSINOGEN I - p. 1679.e3 458. PH, BLOOD - p. 1679.e3 459. Ph, Urine - p. 1679.e3 460. PHENOBARBITAL - p. 1679.e3 461. PHENYTOIN (DILANTIN) - p. 1679.e3 462. PHOSPHATASE, ACID - p. 1680 463. PHOSPHATASE, ALKALINE - p. 1680 464. PHOSPHATE (SERUM) - p. 1680 465. PLASMA CELLS - p. 1680.e1 466. PLASMINOGEN - p. 1680.e1 467. PLATELET AGGREGATION - p. 1680.e1 468. PLATELET ANTIBODIES - p. 1680.e1 469. PLATELET COUNT - p. 1680.e1 470. PLATELET FUNCTION ANALYSIS 100 ASSAY (PFA) - p. 1681.e1 471. PLEURAL FLUID - p. 1681.e1 472. POTASSIUM (SERUM) - p. 1681.e1 473. POTASSIUM, URINE - p. 1682 474. PROCAINAMIDE - p. 1683 475. PROGESTERONE (SERUM) - p. 1683 476. PROLACTIN - p. 1683 477. PROSTATE-SPECIFIC ANTIGEN (PSA) - p. 1683.e1 478. PROSTATIC ACID PHOSPHATASE - p. 1683.e1 479. PROTEIN (SERUM) - p. 1683.e1 480. PROTEIN C ASSAY - p. 1683.e1 481. PROTEIN ELECTROPHORESIS (SERUM) - p. 1683.e1 482. PROTEIN S ASSAY - p. 1683.e2 483. PROTHROMBIN TIME (PT) - p. 1683.e3 484. PROTOPORPHYRIN (FREE ERYTHROCYTE) - p. 1684.e1 485. PSA - p. 1684.e1 486. PT - p. 1684.e1 487. PTH - p. 1684.e1 488. PTT - p. 1684.e1 489. RAPID PLASMA REAGIN (RPR) - p. 1684.e1 490. RDW - p. 1684.e1 491. RED BLOOD CELL (RBC) COUNT - p. 1684.e1 492. RED BLOOD CELL DISTRIBUTION WIDTH (RDW) - p. 1684.e1 493. RED BLOOD CELL FOLATE - p. 1684.e1 494. RED BLOOD CELL MASS (VOLUME) - p. 1684.e1 495. RED BLOOD CELL MORPHOLOGY - p. 1684.e1 496. RENIN (SERUM) - p. 1684.e3 497. RESPIRATORY SYNCYTIAL VIRUS (RSV) SCREEN - p. 1684.e4 498. RETICULOCYTE COUNT - p. 1684.e4 499. RHEUMATOID FACTOR - p. 1685 500. RPR - p. 1685 501. ROTAVIRUS SEROLOGY - p. 1685 502. SARS-COV-2 ANTIBODIES - p. 1685 503. SED RATE - p. 1685 504. SEDIMENTATION RATE - p. 1685 505. SEMEN ANALYSIS - p. 1685 506. SGOT - p. 1685 507. SGPT - p. 1685 508. SICKLE CELL TEST - p. 1685 509. SMOOTH MUSCLE ANTIBODY - p. 1685 510. SODIUM (SERUM) - p. 1685 511. STREPTOZYME - p. 1686.e1 512. SUCROSE HEMOLYSIS TEST (SUGAR WATER TEST) - p. 1686.e1 513. SUDAN III STAIN (QUALITATIVE SCREENING FOR FECAL FAT) - p. 1686.e1 514. SYNOVIAL FLUID ANALYSIS - p. 1686.e1 515. T3 (TRIIODOTHYRONINE) - p. 1686.e2 516. T3 RESIN UPTAKE (T3RU) - p. 1686.e2 517. T4, FREE (FREE THYROXINE) - p. 1686.e2 518. T4, SERUM T4 - p. 1686.e2 519. TEGRETOL - p. 1687.e1 520. TESTOSTERONE (TOTAL TESTOSTERONE) - p. 1687.e1 521. THEOPHYLLINE - p. 1687.e1 522. THORACENTESIS FLUID - p. 1687.e1 523. THROMBIN TIME (TT), THROMBIN CLOTTING TIME (TCT) - p. 1687.e1 524. THYROGLOBULIN - p. 1687.e1 525. THYROID MICROSOMAL ANTIBODIES - p. 1687.e1 526. THYROID-STIMULATING HORMONE (TSH) - p. 1687.e1 527. THYROTROPIN (TSH) RECEPTOR ANTIBODIES - p. 1688 528. THYROTROPIN-RELEASING HORMONE (TRH) STIMULATION TEST - p. 1688 529. THYROXINE (T4) - p. 1688 530. TIBC - p. 1688 531. TISSUE TRANSGLUTAMINASE ANTIBODY - p. 1688 532. TRANSFERRIN - p. 1688 533. TRIGLYCERIDES - p. 1688 534. TRIIODOTHYRONINE - p. 1688 535. TROPONINS (SERUM) - p. 1688 536. TSH - p. 1688.e1 537. TT - p. 1688.e1 538. TUBERCULIN TEST (PPD) - p. 1688.e1 539. UNCONJUGATED BILIRUBIN - p. 1688.e1 540. UREA NITROGEN, BLOOD (BUN) - p. 1689 541. URIC ACID (SERUM) - p. 1689.e1 542. URINALYSIS - p. 1689.e1 543. URINE AMYLASE - p. 1689.e2 544. URINE BILE - p. 1689.e2 545. URINE CALCIUM - p. 1689.e2 546. URINE CAMP - p. 1689.e2 547. URINE CATECHOLAMINES - p. 1689.e2 548. URINE CHLORIDE - p. 1689.e2 549. URINE COPPER - p. 1689.e2 550. URINE CORTISOL, FREE - p. 1689.e2 551. URINE CREATININE (24 H) - p. 1689.e2 552. URINE CRYSTALS - p. 1689.e2 553. URINE EOSINOPHILS - p. 1689.e2 554. URINE GLUCOSE (QUALITATIVE) - p. 1689.e2 555. URINE HEMOGLOBIN, FREE - p. 1689.e2 556. URINE HEMOSIDERIN - p. 1689.e2 557. URINE 5-HYDROXYINDOLE-ACETIC ACID (URINE 5-HIAA) - p. 1689.e2 558. URINE INDICAN - p. 1690.e1 559. URINE KETONES (SEMIQUANTITATIVE) - p. 1690.e1 560. URINE METANEPHRINES - p. 1690.e1 561. URINE MYOGLOBIN - p. 1690.e1 562. URINE NITRITE - p. 1690.e1 563. URINE OCCULT BLOOD - p. 1690.e1 564. URINE OSMOLALITY - p. 1690.e1 565. URINE PH - p. 1690.e1 566. URINE PHOSPHATE - p. 1690.e1 567. URINE POTASSIUM - p. 1690.e1 568. URINE PROTEIN (QUANTITATIVE) - p. 1690.e1 569. URINE SEDIMENT - p. 1690.e1 570. URINE SODIUM (QUANTITATIVE) - p. 1690.e2 571. URINE SPECIFIC GRAVITY - p. 1691 572. URINE VANILLYLMANDELIC ACID (VMA) - p. 1691 573. VARICELLA-ZOSTER VIRUS (VZV) SEROLOGY - p. 1691 574. VASOACTIVE INTESTINAL PEPTIDE (VIP) - p. 1691 575. VDRL - p. 1691 576. VISCOSITY (SERUM) - p. 1691.e1 577. VITAMIN B12 (COBALAMIN) - p. 1691.e1 578. VITAMIN D, 1,25 DIHYDROXY CALCIFEROL - p. 1691.e2 579. VITAMIN K - p. 1691.e2 580. VON WILLEBRAND FACTOR - p. 1691.e2 581. SECTION V. Clinical Practice Guidelines - p. 1693 582. Introduction - p. 1694 583. CLINICAL PRACTICE GUIDELINES—IMMUNIZATIONS AND CHEMOPROPHYLAXIS - p. 1695 584. Appendix - p. 1736.e1 585. Appendix Ia. Definitions of Complementary and Alternative Medicine Terms - p. 1736.e3 586. Appendix Ib. Relaxation Techniques - p. 1736.e5 587. Appendix Ic. Overview of Selected Natural Products - p. 1736.e7 588. Appendix Id. Natural Products and Drug Interactions - p. 1736.e10 589. Appendix Ie. Commonly Ingested Plants with Significant Toxic Potential - p. 1736.e14 590. Appendix If. Herbs Associated with Toxicity - p. 1736.e15 591. Appendix Ig. Websites Providing Data on Herbal Therapy Hazards - p. 1736.e17 592. Appendix Ih. Common Herbs in Integrated Medicine - p. 1736.e18 593. Appendix Ii. Herbal Activities Against Pain and Chronic Diseases - p. 1736.e23 594. Appendix IIa. Dietary Supplements: What Every Primary Care Provider Should Know - p. 1736.e26 595. Appendix IIb. Vitamins and Their Functions - p. 1736.e28 596. Appendix IIc. Nutritional Trace Elements and Their Clinical Implications - p. 1736.e33 597. Appendix IId. Summary of Vitamin and Mineral Deficiencies - p. 1736.e36 598. Appendix IIIa. Selected Historical and Physical Findings in Poisoning - p. 1736.e38 599. Appendix IIIb. Toxidromes - p. 1736.e40 600. Appendix IIIc. Antidotes and Indications for Use - p. 1736.e42 601. Appendix IIId. Management of Acute Poisoning - p. 1736.e47 602. Appendix IIIe. Pathophysiology, Clinical Effects, and Management of Specific Drugs and Toxicants - p. 1736.e50 603. Appendix IIIf. Accidental Poisoning by Exposure to Other Drugs Acting on the Autonomic Nervous System - p. 1736.e54 604. Appendix IV. Impairment and Disability Issues - p. 1736.e56 605. Appendix V. Protection of Travelers - p. 1736.e58 606. Appendix VI. Care of the Transgender Patient - p. 1736.e68 607. Appendix VIII. Palliative Care - p. 1736.e74 608. Appendix IX. Preoperative Evaluation - p. 1736.e79 609. Index - p. 1737 610. End sheet - p. ES3
